miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition.

miR-190 promotes malignant transformation and progression of human urothelial cells through CDKN1B/p27 inhibition.

Huang, Shirui; Hua, Xiaohui; Kuang, Mengjiao; Zhu, Junlan; Mu, Haiqi; Tian, Zhongxian; Zheng, Xiaoqun; Xie, Qipeng.

Afiliación

Huang S; Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Hua X; Department of Occupational Health and Environmental Health, School of Public Health, Anhui Medical University, Hefei, 230032, Anhui, China.
Kuang M; Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Zhu J; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Mu H; Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Tian Z; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Zheng X; School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China.
Xie Q; Department of Laboratory Medicine, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325035, Zhejiang, China. xieqipeng@wmu.edu.cn.

Cancer Cell Int ; 21(1): 241, 2021 Apr 29.

Article en En | MEDLINE | ID: mdl-33926470